Загрузка...
Development of Traceable Rituximab-Modified PEO-Polyester Micelles by Postinsertion of PEG-phospholipids for Targeting of B-cell Lymphoma
[Image: see text] The objective of this work was to develop rituximab (RTX)-modified polymeric micelles for targeting of B-cell lymphoma cells, through postinsertion of RTX-poly(ethylene glycol)-1,2-distearoyl-sn-glycero-3-phosphoethanolamine (RTX-PEG-DSPE) into methoxy poly(ethylene oxide)-poly(ε-c...
Сохранить в:
| Опубликовано в: : | ACS Omega |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Chemical Society
2019
|
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6854837/ https://ncbi.nlm.nih.gov/pubmed/31737848 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsomega.9b02910 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|